References: 1. Yang Y, Lu Y, Tan H, et al. The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer. BMC Cancer. 2023;23(1):422. doi:10.1186/s12885-023-10863-w 2. Guardant Health data on file. October 19, 2023. Guardant Health, Inc. Redwood City, CA. 3. Guardant Health data on file. Guardant Reveal on Infinity. Guardant Health, Inc. Redwood City, CA.
ctDNA-based monitoring provides clarity beyond traditional imaging.
RADIOHEAD: 644 STAGE IV CANCER PATIENTS 1,761 TISSUE-FREE SAMPLES DRAWN ACROSS 4 TIMEPOINTS | MULTIPLE SOLID TUMORS1
Home Screening MRD + Monitoring Treatment Selection
ctDNA, circulating tumor DNA; IO, immunotherapy